Stars and Stripes: Lawmakers, veterans urge FDA to approve ecstasy for treating PTSD in clinical settings
Lawmakers, veterans urge FDA to approve ecstasy for treating PTSD in clinical settings
KELOLAND News: AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin ...
AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin ...
Utah authorizes a state-funded clinical trial studying psychedelic-assisted therapy for veterans with treatment-resistant PTSD, marking a cautious, evidence-first approach to psychedelic research.
6abc News: Supporters think ecstasy has potential to treat PTSD, but FDA panel rejects psychedelic drug
Federal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD. The nonbinding vote is a potential setback for psychedelic advocates hoping to move the banned drugs ...
Supporters think ecstasy has potential to treat PTSD, but FDA panel rejects psychedelic drug
abc13: FDA rejects MDMA in combination with therapy as treatment for PTSD
The U.S. Food and Drug Administration (FDA) has decided not to approve a psychedelic treatment -- along with therapy -- to treat post-traumatic stress disorder (PTSD), according to Lykos Therapeutics, ...
STAT: Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD
Turning a ‘no’ vote into progress: How to advance MDMA-assisted psychotherapy for PTSD
University of Utah Health: Utah authorizes state-funded psychedelic research for veterans with PTSD
MIAMI – The lack of progress in development of drugs to effectively treat posttraumatic stress disorder (PTSD) has become a "crisis" and has led to a significant shift in the US Department of Veterans ...